|
Report No. : |
345912 |
|
Report Date : |
27.10.2015 |
IDENTIFICATION DETAILS
|
Name : |
MULTILAB INDÚSTRIA E COMÉRCIO DE PRODUTOS
FARMACÊUTICOS LTDA |
|
|
|
|
Registered Office : |
Rodovia Rs 401, Km 30,1009 - São Jerônimo 96700-000 - São Jerônimo/Rs |
|
|
|
|
Country : |
Brazil |
|
|
|
|
Date of Incorporation : |
01.08.1988 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacture and Trade of Medicines |
|
|
|
|
No. of Employee : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Brazil |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
BRAZIL - ECONOMIC OVERVIEW
Characterized by large and well-developed agricultural, mining,
manufacturing, and service sectors, and a rapidly expanding middle class,
Brazil's economy outweighs that of all other South American countries, and
Brazil is expanding its presence in world markets. Since 2003, Brazil has
steadily improved its macroeconomic stability, building up foreign reserves,
and reducing its debt profile by shifting its debt burden toward real
denominated and domestically held instruments. Since 2008, Brazil became a net
external creditor and all three of the major ratings agencies awarded
investment grade status to its debt. After strong growth in 2007 and 2008, the
onset of the global financial crisis hit Brazil in 2008. Brazil experienced two
quarters of recession, as global demand for Brazil's commodity-based exports
dwindled and external credit dried up. However, Brazil was one of the first
emerging markets to begin a recovery. In 2010, consumer and investor confidence
revived and GDP growth reached 7.5%, the highest growth rate in the past 25
years. After reaching historic lows of 4.5% in early 2014, the unemployment
rate remains low, but is rising. Brazil's traditionally high level of income
inequality has declined for each of the last 15 years. GDP growth has slowed
since 2011, due to several factors, including: overdependence on exports of raw
commodities, low productivity, high operational costs, persistently high
inflation, and low levels of investment. Brazil's fiscal and current account
balances have eroded during the past four years as the government attempted to boost
economic growth through targeted tax cuts for industry and incentives to spur
household consumption. After winning reelection in October 2014 by a
historically narrow margin, President Dilma ROUSSEFF appointed a new economic
team led by Finance Minister Joaquim LEVY, who introduced a fiscal austerity
package intended to restore the primary account surplus to 1.2% of GDP and
preserve the country's investment-grade sovereign credit rating. Brazil seeks
to strengthen its workforce and its economy over the long run by imposing local
content and technology transfer requirements on foreign businesses, by
investing in education through social programs such as Bolsa Familia and the
Brazil Science Mobility Program, and by investing in research in the areas of space,
nanotechnology, healthcare, and energy.
|
Source
: CIA |
MULTILAB
INDÚSTRIA E COMÉRCIO DE PRODUTOS FARMACÊUTICOS LTDA
|
MAIN ADDRESS: |
RODOVIA RS 401, KM 30,1009 - SÃO JERÔNIMO |
|
ZIP CODE/CITY: |
96700-000 - SÃO JERÔNIMO/RS |
|
|
|
|
PHONE: |
51 3055-9000 |
|
FAX: |
51 3055-9000 |
|
E-MAIL: |
rodrigo.espim@takeda.com |
|
WEB SITE: |
www.multilab.com.br |
|
BRANCHES: |
|
|
|
|
|
ADDRESS: |
RUA MARIANO DE MATOS,742 |
|
ZIP CODE/CITY: |
90880-250 PORTO ALEGRE/RS |
|
|
|
|
ADDRESS: |
AV. INSUTRIAL BELGRAF,250 CENTRO |
|
ZIP CODE/CITY: |
92990-000 ELDORADO SUL SUL/RS |
|
PHONE: |
51 3230-4043 |
|
MAIN ACTIVITIES: |
|
MANUFACTURE AND TRADE OF MEDICINES. |
|
LEGAL FORM: |
LIMITED
LIABILITY COMPANY |
|
|
|
|
INCORPORATION DATE: |
01/08/1988 |
|
REGISTER DATE: |
04/08/1988 |
|
BALANCE SHEET FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR NUMBER(CNPJ): |
92.265.552/0001-40 |
|
STATE REGISTER: |
121/0050568 |
|
|
|
|
SHARE CAPITAL: |
R$ 527.545.742,00 |
|
BOARD OF
DIRECTORS: |
|
|
|
|
|
RICARDO WERNER MAREK |
MANAGER |
|
EDUARDO JOSE MARTINS |
MANAGER |
|
THE MANAGERS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS /
PARTNERS: |
|
|
|
|
|
TAKEDA PHARMA AS |
99,99% |
|
TAKEDA EUROPE HOLDINGS B V |
00,01% |
|
AFFILIATES /
SUBSIDIARIES: |
|
|
A SCAN THROUGH OUTSIDE SOURCES SHOWED THE SUBJECT AND/OR PARTNERS
HAS/HAVE THE FOLLOWING UNCONFIRMED HOLDINGS: |
|
|
TAKEDA GROUP |
|
|
THE SUBJECT WAS ESTABLISHED ON AUGUST 01, 1988 TO BE ENGAGED IN THE
SAID LINE OF BUSINESS AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL
SCENE REPORTED HEREIN. TRADE NAME: "MULTILAB". CONTACTS WERE MADE THROUGH THE RELATED PARTY TAKEDA DISTRIBUIDORA LTDA
LOCALIZADA NO SITUATED AT AV. PORTUGUAL, 1100, RUA MODULO A 8, ITAPEVI - SP
CEP 06696-060, TAXPAYER NUMBER CNPJ 11.635.171/0001-03, TELEPHONE 11
5188-4400. REMARKS: ACCORDING TO AMENDMENT TO THE ARTICLES OF INCORPORATION DATED OF JULY
02, 2012 (AND PURCHASE AND SALE OF SHARES CONTRACT DATED OF MAY 25, 2012) THE
PARTNERS GENÉSIO CERVO AND TERESINHA GOBBI, WITHDREW FROM THE PARTNERSHIP AND
TRANSFERRED THE TOTALITY OF SHARES TO TAKEDA FARMACÊUTICA BRASIL LTDA., WHICH
BELONGS TO THE TAKEDA GROUP FROM JAPAN. OUTSIDE SOURCES STATED THAT
ACQUISITION AMOUNTED TO R$ 540 MILLIONS. FURTHER, IN 2011 THE TAKEDA GROUP
ALSO ACQUIRED NYCOMED FROM SWITZERLAND FOR THE AMOUNT OF 14 BILLION. FURTHER, WE HAVE BEEN INFORMED THAT SUBJECT HAS TAKEN OVER ITS
CONTROLLER TAKEDA FARMACÊUTICA BRASIL LTDA. HOWEVER, WHEN CONSULTING THE
STATE OF RIO GRANDE DO SUL REGISTER OF COMPANIES TAKEDA FARMACÊUTICA BRASIL
LTDA. STILL APPEARS AS THE COMPANY'S CONTROLLER. THE SUBJECT MUST FILE AN
AMENDMENT TO THE REGISTER OF COMPANIES INFORMING THAT THE TAKEOVER HAS
OCCURRED AND APPOINT THE NEW PARTNERSHIP COMPOSITION. IN THE MEANTIME WE WILL
BE INFORMING THE COMPANY'S PARTNER ACCORDING TO THE REGISTER OF COMPANIES. REMARKS: -------- WHEN CONTACTING THE SUBJECT WE INTERVIEWED MR. RODRIGO ESPIM -
FINANCIAL DEPARTMENT, WHO INFORMED THAT WOULD NOT DISCLOSE ANY KIND OF
INFORMATION UNLESS THE INQUIRING PARTY'S NAME WAS DISCLOSED. IF IT IS POSSIBLE TO DISCLOSE THE NAME OF THE INTERESTED SUPPLIER OF
THE SUBJECT, WE MAY RESUME OUR CONTACTS AND TRY TO OBTAIN FURTHER
INFORMATION. THE DATA CONTAINED HEREIN WERE OBTAINED FROM OUTSIDE SOURCES, OUR
DATABASE AND OFFICIAL. NO FURTHER DATA WAS AVAILABLE WITH SEVERAL SOURCES
USUALLY INVESTIGATED. |
|
PUBLIC INFORMATION: |
|
PROTESTS: |
|
5 PROTESTS,TOTAL AMOUNT R$
43.855,38 |
|
DETAILS OF
LATEST PROTESTS: |
|
NOTARY OFFICE: |
DATE: |
VALUE: |
|
1º CARTÓRIO DE SÃO JERÔNIMO-RS |
06/10/2015 |
R$ 16.430,00 |
|
1º CARTÓRIO DE SÃO JERÔNIMO-RS |
14/10/2015 |
R$ 1.143,00 |
|
1º CARTÓRIO DE SÃO JERÔNIMO-RS |
02/10/2015 |
R$ 394,00 |
|
1º CARTÓRIO DE SÃO JERÔNIMO-RS |
02/10/2015 |
R$ 142,04 |
|
1º CARTÓRIO DE SÃO JERÔNIMO-RS |
02/10/2015 |
R$ 25.746,34 |
|
DUE TO THE SUBJECT'S LEGAL FORM, IT IS NOT OBLIGED TO PUBLISH THE
BALANCE SHEET INFORMATION. WHEN INTERVIEWING SOURCES AT THE SUBJECT COMPANY
DECLINED TO PROVIDE ANY KIND OF FINANCIAL INFORMATION. OUR INVESTIGATION THROUGH THE OUTSIDE SOURCES SHOWED NO FINANCIAL DATA
ABOUT THE SUBJECT. |
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$ 3,93 |
- OFFICIAL RATE ON 21/10/2015 |
|
COMMENTS ON THE
FINANCIAL INFORMATION: |
|
IN THE ABSENCE OF FINANCIAL INFORMATION NO COMMENTS CAN BE MADE ABOUT THE
SUBJECT'S CURRENT FINANCIAL STANDING. |
|
REAL ESTATE: |
OWNED PREMISES ARE VALUED AT R$ 14.547.933,64
|
VEHICLES: |
OWNED VEHICLES ARE VALUED AT R$ 79.452,47
|
MACHINES: |
OWNED MACHINES AND EQUIPMENTS ARE VALUED AT R$ 12.527.895,24
|
THE COMPANY CONTRACTS INSURANCE OVER ITS OPERATIONAL ASSETS IN AMOUNTS
CONSIDERED ADEQUATE BY ITS MANAGEMENT |
|
|
BRANCH/PHONE: |
|
|
BANCO DO BRASIL S/A |
3418-5 / 51 3214-7676 |
|
|
BANCO BANRISUL S/A |
047 / 51 3223-1799 |
|
|
BANCO SAFRA S/A |
51 2131-3746 |
|
|
REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE
INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW
PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS. ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY
HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682
BRAZILIAN CENTRAL BANK"). |
|
SUBJECT IS ENGAGED IN THE MANUFACTURE AND TRADE OF MEDICINES. |
|
IMPORT AND
EXPORT: |
IMPORTS FROM:
|
ITALY, GERMANY, MEXICO, CANADA AND INDIA. |
EXPORTS TO:
|
DOES NOT EXPORT. |
|
MAIN CLIENTS: |
|
|
|
|
|
|
|
DOMESTIC
CLIENTS: |
|
PHONE: |
|
CERVOSUL DISTRIB MEDICAMENTOS LTDA |
|
51 3230-4000 |
|
DISTRIBUIDORA BRINGEL LTDA |
|
92 2126-4000 |
|
DIVAMED DISTR IRMÃOS VALOTTO MEDIC |
|
14 3405-5500 |
|
EMEFARMA RIO REPRESENTAÇÕES LTDA |
|
21 2187-8900 |
|
GALINDO DIT E REPRES LTDA (PE) |
|
81 3343-8999 |
|
GAUCH FARMA MEDICAMENTOS LTDA |
|
51 3382-2200 |
|
GERRAFARMA DISTR E REPRES LTDA |
|
86 3221-2359 |
|
GLOBO FARMA DISTRIBUIDORA LTDA |
|
75 3603-7800 |
|
MS FARMA COMERCIAL LTDA |
|
75 3224-0228 |
|
NORTEFARMA COMÉRCIO LTDA |
|
84 3661-2393 |
|
PRODIET FARMACEUTICA S/A |
|
41 2169-4848 |
|
TAPAJOS DISTR DE PROD FARMAC LTDA |
|
92 2123-4000 |
|
TOTAL COMERCIO E REPRESENTAÇÕES LTDA |
|
85 3311-2350 |
|
STAFF: |
|
|
|
NOT AVAILABLE |
|
THE SUBJECT IS A WELL-ESTABLISHED COMPANY, OPERATING SINCE 1988. SO FAR
IT HAS A CLEAR TRADE HISTORY AND NO PAYMENT PROBLEMS ARE NOTED. THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE
SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS
ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED. THE PROTESTS FOUND ARE NOT RELEVANT. |
|
MAIN SUPPLIERS: |
|
|
|
|
|
|
|
DOMESTIC
SUPPLIERS: |
|
PHONE: |
|
AB FARM QUIMICA LTDA |
|
62 3316-3420 |
|
BRASKAP COMERCIO E INDÚSTRIA S/A |
|
15 3225-3355 |
|
CASA DA QUIMICA |
|
11 4043-2855 |
|
COLORCON DO BRASIL LTDA |
|
11 4617-8669 |
|
COMERCIAL REBESCHINI DE ÁLCOOL |
|
51 3336-1809 |
|
FARMAPLAST IND EMBALAGENS PLÁSTICAS |
|
11 4612-2700 |
|
GENIX INDUSTRIA FARMACEUTICA LTDA |
|
11 2067-5600 |
|
GRAFICA LOTICOMART LTDA |
|
51 3041-3434 |
|
IPIRANGA QUIMICA DIVISÃO EMCA |
|
11 3245-4416 |
|
M CASSAB COM IND LTDA |
|
11 2162-7609 |
|
NILCATEX TEXTIL LTDA. |
|
47 3231-2500 |
|
NORTIS FRMACÊUTICA LTDA |
|
43 3443-2244 |
|
TROMBINI INDUSTRIAL S/A |
|
51 2129-2300 |
|
VALDEQUIMICA PRODUTOS QUIMICOS |
|
11 3721-1077 |
|
VEDAT TAMPAS |
|
51 3217-1177 |
|
WHEATON DO BRASIL INDÚSTRIA COMÉRCIO |
|
51 3217-1177 |
|
FOREIGN
SUPPLIERS: |
COUNTRY: |
|
|
FERSINSA GB |
MEXICO |
|
|
LA FIDUCIARIA |
ITALY |
|
|
LEE PHARMA |
INDIA |
|
|
PAYMENT HISTORY: |
|
06 SUPPLIERS REPORTED PAYMENTS: |
|
TOTAL AMOUNT: R$ 167.832,00 |
|
|
|
AMOUNT OF INVOICES PAID: 15 |
|
TOTAL OF PROMPT PAYMENTS: 98,3% |
|
TOTAL OF DELAYED PAYMENTS: 1,7% |
|
|
|
HIGHEST INVOICE: R$ 62.078,00 |
|
HIGHEST CREDIT: R$ 62.078,00 |
|
|
|
OUTSTANDING
INVOICES DUE WITHIN THE NEXT 30 DAYS: |
|
--------------------------- |
SUPPLIERS: |
INVOICES: |
TOTAL AMOUNT: |
|
DUE WITHIN 30 DAYS |
2 |
2 |
R$ 10.785,60 |
|
BASED ON THE OVERALL DATA AVAILABLE THE SUBJECT MAY BE CONSIDERED FOR
NORMAL BUSINESS COMMITMENTS. CREDIT FACILITIES HOWEVER SHOULD BE GRANTED ON
FULLY SECURED TERMS ONLY DUE TO THE ABSENCE OF FINANCIAL DATA. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.64.96 |
|
|
1 |
Rs.99.54 |
|
Euro |
1 |
Rs.71.64 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
SDA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome
financial difficulties seems comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.